Latest News and Press Releases

TORONTO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company has changed its...

Scythian Invests USD$88 Million in Verano Class B Membership Units Scythian to Sell 3 Boys Farms in Share Exchange for USD$100 Million in Verano Class B Membership Units M&A Identified, Talent...

Scythian’s Chief Medical Officer, The Famed Dr. Barnes, Receives National Praise for His Advocacy, Education and Tireless Leadership from Government, Media and Medical Organizations to Assist in...

Florida Department of Health Approves CannCure’s Purchase of 60% of the Equity of 3 Boys Farms Including the License to Operate as a Medical Marijuana Treatment Center in Florida 3 Boys Farms Gets...

TORONTO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today Brady Cobb, a leading voice...

TORONTO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (“Scythian” or the “Company”) (CSE:SCYB) (Frankfurt: 9SB) (OTC – Nasdaq Intl: SCCYF) announced its intention to commence a...

TORONTO, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Peter Liabotis, a veteran senior corporate finance executive and certified public accountant, has been appointed Chief Financial Officer of Scythian...

Scythian Received 15,678,310 common shares of Aphria Inc. as Consideration for the Sale Scythian’s Current Number of Issued and Outstanding Common Shares is 48,849,218 TORONTO, Sept. 27, 2018 ...

Closing of Argentine Acquisition is Key Benchmark in Finalization of Previously Announced $193 Million Sale of Assets in Latin America, Which as of Prior Day Close was Valued At Approximately $313...

Shareholders Approve Strategic Sale of Latin American Assets to Aphria in Exchange for 15,678,310 shares of Aphria (TSX:APH) Shareholders Approve Name Change to SOL Investments Corp. Scythian’s...